About Personalis
Personalis is a company based in Menlo Park (United States) founded in 2011.. Personalis has raised $87.3 million across 5 funding rounds from investors including Merck, Lightspeed Venture Partners and Leland Stanford Junior University. The company has 229 employees as of December 31, 2024. Personalis operates in a competitive market with competitors including MedGenome, Foundation Medicine, Tempus, Veritas Genetics and CancerIQ, among others.
- Headquarter Menlo Park, United States
- Employees 229 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Personalis, Inc.
-
Annual Revenue
$84.61 M15.15as on Dec 31, 2024
-
Net Profit
$-81.28 M24.94as on Dec 31, 2024
-
EBITDA
$-57.33 M32.56as on Dec 31, 2024
-
Total Equity Funding
$87.3 M (USD)
in 5 rounds
-
Latest Funding Round
$50 M (USD), Post-IPO
Dec 19, 2024
-
Investors
Merck
& 5 more
-
Employee Count
229
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Personalis
Personalis is a publicly listed company on the NASDAQ with ticker symbol PSNL in USA, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Funding Insights of Personalis
Personalis has successfully raised a total of $87.3M across 5 strategic funding rounds. The most recent funding activity was a Post-IPO round of $50 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Post-IPO — $50.0M
-
First Round
First Round
(01 Oct 2011)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2024 | Amount | Post-IPO - Personalis | Valuation |
investors |
|
| Jul, 2017 | Amount | Series C - Personalis | Valuation |
investors |
|
| Dec, 2014 | Amount | Series C - Personalis | Valuation | Lightspeed Venture Partners |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Personalis
Personalis has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Merck, Lightspeed Venture Partners and Leland Stanford Junior University. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investing in innovative companies across global sectors is undertaken by Lightspeed Venture Partners.
|
Founded Year | Domain | Location | |
|
Venture capital investments are managed in technology and healthcare sectors by this firm.
|
Founded Year | Domain | Location | |
|
Early stage venture capital firm investing in US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Personalis
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Personalis
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Personalis Comparisons
Competitors of Personalis
Personalis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MedGenome, Foundation Medicine, Tempus, Veritas Genetics and CancerIQ, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
DNA sequencing, bioinformatics, and multiomics services are provided.
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
AI-based precision medicine solutions for oncology are provided.
|
|
| domain | founded_year | HQ Location |
Genetic testing products for health risks and traits are offered.
|
|
| domain | founded_year | HQ Location |
CancerIQ is focused on precision cancer prevention and care.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Personalis
Frequently Asked Questions about Personalis
When was Personalis founded?
Personalis was founded in 2011.
Where is Personalis located?
Personalis is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
Is Personalis a funded company?
Personalis is a funded company, having raised a total of $87.3M across 5 funding rounds to date. The company's 1st funding round was a Series C of $33M, raised on Oct 01, 2011.
How many employees does Personalis have?
As of Dec 31, 2024, the latest employee count at Personalis is 229.
What is the annual revenue of Personalis?
Annual revenue of Personalis is $84.61M as on Dec 31, 2024.
What does Personalis do?
Personalis was founded in 2011 and is headquartered in Menlo Park, United States. Services in the healthcare sector focus on genomic sequencing of DNA, RNA, augmented exome, and targeted transcriptome. Products such as the ImmunoID NeXT platform support precision oncology through analytical algorithms for immune checkpoints and related information. Additional offerings include RepertoireID for tumor sample analysis, ImmunogenomicsID, and NeoantigenID.
Who are the top competitors of Personalis?
Personalis's top competitors include Tempus, Foundation Medicine and MedGenome.
Is Personalis publicly traded?
Yes, Personalis is publicly traded on NASDAQ under the ticker symbol PSNL.
Who are Personalis's investors?
Personalis has 6 investors. Key investors include Merck, Lightspeed Venture Partners, Leland Stanford Junior University, Abingworth, and Mohr Davidow Ventures.
What is Personalis's ticker symbol?
The ticker symbol of Personalis is PSNL on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.